The overall goal of this Program Project is to generate novel chemical libraries based on potent natural product-derived pharmacophores and to identify promising new lead structures that affect-cancer relevant molecular targets. We intend to exploit recent advances in solid phase and solution phase combinatorial chemistry developed in our laboratories to synthesize unique natural product-based small-molecule libraries. Our synthetic efforts in Project #1 are focused on two highly relevant molecular targets for cancer, namely tubulin, which is the critical target of several clinically active anti-cancer agents, including paclitaxel, vincristine and vinblastine, and dual specificity phosphatase that have been documented to be proto oncogenes and regulators of cell cycle progression. Projects #2 and 3 will be responsible for the in vitro biochemical analyses of compounds generated by Project #1 as well as initial cell proliferation and cell cycle assays. Project #2 will examine the anti-phosphatase activity of newly synthesized library members while Project #3 will evaluate microtubulin disrupting properties in vitro; both Projects will determine the anti-proliferative activity in at least three representative human tumor cell lines. Project #4 will employ high content combinatorial cell biological assays to both validate in vitro assays and further characterize the actions of each compound. Additionally, Project #4 will develop novel temporal-and spatial-sensitive cellular assays suitable for high throughput that may be applicable to a wide variety of cancer-related signal transduction and cell structural targets. With the assistance of the Quantitative Structural Activity Relationship (QSAR)/Bioinformatics Core B, data from each Project will be analyzed to further refine the basic pharmacophore design and substituent content. Preclinical evaluation of the anti-tumor activity or prioritized lead compounds will conducted in Programs #2 and 3 to provide an initial assessment of overall therapeutic potential. The activities of the program Project will be coordinated by the Administrative Core A. Thus, this Program Project combines the power of contemporary chemistry, biology and informatics in an integrated, interdisciplinary manner that is focused on cancer cure.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
3P01CA078039-05S1
Application #
6882171
Study Section
Special Emphasis Panel (ZCA1)
Program Officer
Lees, Robert G
Project Start
1998-05-15
Project End
2005-02-28
Budget Start
2002-03-01
Budget End
2005-02-28
Support Year
5
Fiscal Year
2004
Total Cost
$124,688
Indirect Cost
Name
University of Pittsburgh
Department
Pharmacology
Type
Schools of Medicine
DUNS #
004514360
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
McCabe, Stephanie R; Wipf, Peter (2016) Total synthesis, biosynthesis and biological profiles of clavine alkaloids. Org Biomol Chem 14:5894-913
George Rosenker, Kara M; Paquette, William D; Johnston, Paul A et al. (2015) Synthesis and biological evaluation of 3-aminoisoquinolin-1(2H)-one based inhibitors of the dual-specificity phosphatase Cdc25B. Bioorg Med Chem 23:2810-8
Korotchenko, Vasiliy N; Saydmohammed, Manush; Vollmer, Laura L et al. (2014) In vivo structure-activity relationship studies support allosteric targeting of a dual specificity phosphatase. Chembiochem 15:1436-45
Guo, Jianxia; Clausen, Dana M; Beumer, Jan H et al. (2013) In vitro cytotoxicity, pharmacokinetics, tissue distribution, and metabolism of small-molecule protein kinase D inhibitors, kb-NB142-70 and kb-NB165-09, in mice bearing human cancer xenografts. Cancer Chemother Pharmacol 71:331-44
Salum, Lívia B; Altei, Wanessa F; Chiaradia, Louise D et al. (2013) Cytotoxic 3,4,5-trimethoxychalcones as mitotic arresters and cell migration inhibitors. Eur J Med Chem 63:501-10
Wang, Y; Lazo, J S (2012) Metastasis-associated phosphatase PRL-2 regulates tumor cell migration and invasion. Oncogene 31:818-27
Arora, Reety; Shuda, Masahiro; Guastafierro, Anna et al. (2012) Survivin is a therapeutic target in Merkel cell carcinoma. Sci Transl Med 4:133ra56
Kitchens, Carolyn A; McDonald, Peter R; Shun, Tong Ying et al. (2011) Identification of chemosensitivity nodes for vinblastine through small interfering RNA high-throughput screens. J Pharmacol Exp Ther 339:851-8
Vollmer, Laura L; Jiménez, Maria; Camarco, Daniel P et al. (2011) A simplified synthesis of novel dictyostatin analogues with in vitro activity against epothilone B-resistant cells and antiangiogenic activity in zebrafish embryos. Mol Cancer Ther 10:994-1006
Hopkins, Chad D; Schmitz, John C; Chu, Edward et al. (2011) Total synthesis of (-)-CP2-disorazole C1. Org Lett 13:4088-91

Showing the most recent 10 out of 106 publications